| CASE REPORT |
|
| Year : 2015 | Volume
: 12
| Issue : 2 | Page : 145-147 |
|
|
Acute pulmonary embolism after the use of pegylated interferon and ribavirin
Altug Osken1, Ramazan Akdemir2, Yasemin Gunduz3, Huseyin Gunduz2
1 Department of Cardiology, Siyami Ersek Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, Turkey
2 Department of Cardiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey
3 Department of Radiology, Sakarya University, Faculty of Medicine, Sakarya, Turkey
Correspondence Address:
Altug Osken
19 Mayis Mah. Bayar Cad. Ipek Apt. No: 9/5, Kozyatagi, Kad?koy, Istanbul - 34742
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0189-7969.152033
|
|
|
Liver disease may lead to both reduced and increased risk of venous thromboembolism (VTE) caused by the changes in the coagulation cascade. We present a case of pulmonary embolism after the use of pegylated interferon (peg-IFN) plus ribavirin for treatment of chronic hepatitis C (CHC). Echocardiography revealed thrombus imaging in the pulmonary bifurcation zone and the patient treated successfully with thrombolytic therapy. Hemostatic work up showed no significant abnormalities. In the absence of underlying diseases and predisposing factors, drug interactions and incidental co-existence of pulmonary embolism should be kept in mind. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
